Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07427719

Retinopathy of Prematurity - Visual Function and Retinal Structure

Sponsor: Oslo University Hospital

View on ClinicalTrials.gov

Summary

Children born prematurely may develop a characteristic retinal disease named retinopathy of prematurity (ROP). This disease could lead to retinal detachment and blindness. ROP was traditionally treated with laser, but injection with a medication (A-VEGF) has become more common. In this study, the researchers will explore whether treatment of ROP affects visual function and retinal development. To explore this, the study group will examine children with ROP (but not treated) with children treated with either laser or injection. The researchers will compare the children's visual functions (e.g. visual acuity and visual field) and their retinas (e.g. central and peripheral retina).

Official title: Children Treated for Retinopathy of Prematurity - Study of Visual Function and Retinal Structure

Key Details

Gender

All

Age Range

6 Years - 20 Years

Study Type

OBSERVATIONAL

Enrollment

140

Start Date

2026-04-01

Completion Date

2029-06-01

Last Updated

2026-02-23

Healthy Volunteers

No

Locations (1)

Oslo University Hospital

Oslo, Oslo County, Norway